← Oxford Biomedica
What podcasts say about Oxford Biomedica
Every statement, with the speaker, the exact quote and the moment it was said.
What experts have said about Oxford Biomedica
5 statements · 5 negative
Oxford Biomedica cut its full-year revenue and profitability guidance.
“they cut their full year revenue and profitability guidance.”
Open the episode · Frasers Group Up, Royal Unibrew Drops, OXB DownListen at 4:05
Oxford Biomedica is loss-making and consuming cash, complicating valuation.
“It's loss-making and cash-burning, so it's quite a leap of faith here to actually value it.”
Open the episode · Paul's Podcast - Fri 7 Aug 2026Listen at 14:59
Oxford Biomedica is currently far below its revenue target.
“it's nowhere near that level at the moment.”
Open the episode · Paul's Podcast - Fri 7 Aug 2026Listen at 15:32
Paul would not personally invest in Oxford Biomedica.
“So it's not the sort of thing I would personally invest in.”
Open the episode · Paul's Podcast - Fri 7 Aug 2026Listen at 15:44
Paul Scott would not personally invest in Oxford Biomedica.
“It's not the sort of thing I would personally invest in.”
Open the episode · Paul's Podcast - Fri 7 Aug 2026Listen at 15:45
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.